Alembic is currently trading at Rs. 45.40, up by 0.40 points or 0.89% from its previous closing of Rs. 45.00 on the BSE.
The scrip opened at Rs. 46.45 and has touched a high and low of Rs. 47.00 and Rs. 44.75 respectively. So far 154392 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 72.00 on 24-Jan-2018 and a 52 week low of Rs. 33.85 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 49.95 and Rs. 41.00 respectively. The current market cap of the company is Rs. 1181.20 crore.
The promoters holding in the company stood at 63.71%, while Institutions and Non-Institutions held 7.18% and 29.11% respectively.
Jyoti Suresh Patel, Immediate Relative of the promoter of Alembic has bought 30,000 equity shares of the company for an amount of Rs 12.89 lakh through open market purchase on June 11, 2018. Her stake has increased to 9,68,897 equity shares or 0.38% from 9,38,897 equity shares or 0.37%.
The company is engaged in manufacturing of active pharmaceutical ingredients for anti-parkinsons, anti-depressants, cephalosporins, macrolides and others.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |